title: Question 2: Blast from the past: is oral salbutamol useful in resource-poor settings?
authors.affiliation: Paediatric Department, Scarborough Hospital, North Yorkshire, UK.
authors.forename: Dominic Anthony
authors.initials: DA
authors.lastname: O'Reilly
authors.affiliation: Paediatric Department, PCEA Chogoria Hospital, Near Meru, Tharaka Nithi County, Kenya.
authors.forename: Abdi
authors.initials: A
authors.lastname: Awale
authors.affiliation: Paediatric Department, Leeds General Infirmary, Leeds, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Cartledge
mesh_terms: D000284:Administration, Oral; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage* / Q000627:therapeutic use; D000420:Albuterol / Q000008:administration & dosage* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002675:Child, Preschool; D003906:Developing Countries; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D007630:Kenya; D008507:Medically Underserved Area
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D000420:Albuterol
keywords: Evidence Based Medicine; Paediatric Practice; Respiratory